Latest News about CUE
Recent news which mentions CUE
3 Biotech Stocks Sitting on Huge-Upside Catalysts
May 26, 2023
From InvestorPlace
7 Hot Growth Stocks Poised to Triple in 2023
May 05, 2023
From InvestorPlace
7 High-Potential Penny Stocks in the Biotech Sector
May 04, 2023
Tags
NASDAQ:CUE,NASDAQ:SANA,NASDAQ:PGEN,NASDAQ:ATOS,NASDAQ:BLRX,NASDAQ:CRVS,NASDAQ:ARDX
BLRX
Stocks to Buy
From InvestorPlace
Earnings Scheduled For March 21, 2023
March 21, 2023
From Benzinga
From InvestorPlace
Why Soluna Holdings Shares Are Trading Sharply Lower; Here Are 38 Stocks Moving Premarket
October 24, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 04, 2022
From Benzinga
Why AeroClean Technologies Shares Are Trading Higher By Around 38%, Here Are 58 Stocks Moving In Tuesday's Mid-Day Session
October 04, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 01, 2022
From Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 22, 2022
From Benzinga
Cue Biopharma Shares Decline Following Initial-Stage Metastatic Cancer Study Kicks-off
August 22, 2022
Tickers
CUE
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
June 28, 2022
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 05, 2022
From Benzinga
64 Biggest Movers From Yesterday
March 18, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 02, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
February 08, 2022
From Benzinga
52 Biggest Movers From Friday
January 31, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 28, 2022
From Benzinga
33 Stocks Moving In Friday's Mid-Day Session
January 28, 2022
From Benzinga
64 Biggest Movers From Yesterday
January 28, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 27, 2022
From Benzinga
46 Stocks Moving In Thursday's Mid-Day Session
January 27, 2022
From Benzinga
The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study
January 27, 2022
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.